Literature DB >> 18791466

Oxidative stress and inflammation in atrial fibrillation: role in pathogenesis and potential as a therapeutic target.

David R Van Wagoner1.   

Abstract

Atrial fibrillation (AF) is one of the most prevalent and vexing cardiovascular conditions. Available treatments for AF based on ion channel blockade are only poorly effective. The fundamental mechanisms that underlie AF are still not clearly understood, and likely vary depending on the etiology of AF. In older individuals with senile AF, likely mechanisms include abnormal calcium cycling, oxidant stress, and deleterious inflammatory responses. Clinical and experimental evidence is provided to support the role of oxidant and inflammatory mechanisms in AF. On the basis of these studies, the prospects of manipulating oxidant and inflammatory pathways as targets for therapeutic intervention are discussed.

Entities:  

Mesh:

Year:  2008        PMID: 18791466     DOI: 10.1097/FJC.0b013e31817f9398

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  74 in total

1.  Oxidative stress fine-tunes the dance of hERG K+ channels.

Authors:  Jamie I Vandenberg
Journal:  J Physiol       Date:  2010-08-15       Impact factor: 5.182

Review 2.  New developments in atrial antiarrhythmic drug therapy.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Nat Rev Cardiol       Date:  2010-03       Impact factor: 32.419

Review 3.  Atrial remodeling, fibrosis, and atrial fibrillation.

Authors:  José Jalife; Kuljeet Kaur
Journal:  Trends Cardiovasc Med       Date:  2014-12-31       Impact factor: 6.677

4.  A preliminary study about the effects of warm priming solution on oxidative stress and postoperative atrial fibrillation in open heart surgery.

Authors:  Mustafa Buyukates; Serefden Acikgoz; Erol Aktunc; Ozer Kandemir; Sait Mesut Dogan; Mustafa Aydin
Journal:  Wien Klin Wochenschr       Date:  2012-08-10       Impact factor: 1.704

Review 5.  Novel pharmacological targets for the rhythm control management of atrial fibrillation.

Authors:  Alexander Burashnikov; Charles Antzelevitch
Journal:  Pharmacol Ther       Date:  2011-08-17       Impact factor: 12.310

6.  Characterization of cardiac oxidative stress levels in patients with atrial fibrillation.

Authors:  Ayako Okada; Yuichiro Kashima; Takeshi Tomita; Takahiro Takeuchi; Kazunori Aizawa; Masafumi Takahashi; Uichi Ikeda
Journal:  Heart Vessels       Date:  2014-09-27       Impact factor: 2.037

Review 7.  Serine/Threonine Phosphatases in Atrial Fibrillation.

Authors:  Jordi Heijman; Shokoufeh Ghezelbash; Xander H T Wehrens; Dobromir Dobrev
Journal:  J Mol Cell Cardiol       Date:  2017-01-07       Impact factor: 5.000

Review 8.  Antioxidant therapies for the management of atrial fibrillation.

Authors:  Tong Liu; Panagiotis Korantzopoulos; Guangping Li
Journal:  Cardiovasc Diagn Ther       Date:  2012-12

Review 9.  Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target.

Authors:  Dobromir Dobrev
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-09-26       Impact factor: 3.000

10.  Prevention of atrial fibrillation: report from a national heart, lung, and blood institute workshop.

Authors:  Emelia J Benjamin; Peng-Sheng Chen; Diane E Bild; Alice M Mascette; Christine M Albert; Alvaro Alonso; Hugh Calkins; Stuart J Connolly; Anne B Curtis; Dawood Darbar; Patrick T Ellinor; Alan S Go; Nora F Goldschlager; Susan R Heckbert; José Jalife; Charles R Kerr; Daniel Levy; Donald M Lloyd-Jones; Barry M Massie; Stanley Nattel; Jeffrey E Olgin; Douglas L Packer; Sunny S Po; Teresa S M Tsang; David R Van Wagoner; Albert L Waldo; D George Wyse
Journal:  Circulation       Date:  2009-02-03       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.